KULICKE & SOFFA INDUSTRIES INC
0000056978
false
Singapore
0000056978
2024-05-01
2024-05-01
0000056978
dei:OtherAddressMember
2024-05-01
2024-05-01
                                 UNITED STATES                                  
                       SECURITIES AND EXCHANGE COMMISSION                       
                             Washington, D.C. 20549                             
                                                                                
              ____________________________________________________              
                                      FORM                                      
                                      8-K                                       
              ____________________________________________________              

                                 CURRENT REPORT                                 
                     Pursuant to Section 13 or 15(d) of the                     
                        Securities Exchange Act of 1934                         

               Date of report (Date of earliest event reported):                
                                  May 1, 2024                                   
                                                                                
              ____________________________________________________              
                       KULICKE AND SOFFA INDUSTRIES, INC.                       
             (Exact name of registrant as specified in its charter)             
                                                                                
                                                                                
              ____________________________________________________              
                                                                                

         Pennsylvania                     000-00121                  23-1498399      
 (State or Other Jurisdiction      (Commission File Number)       (I.R.S. Employer   
      of Incorporation)                                          Identification No.) 


     

                                                                                
                          23A Serangoon North Avenue 5                          
                                       ,                                        
                                     #01-01                                     
                                       ,                                        
                                   Singapore                                    
                                     554369                                     
                               1005 Virginia Dr.                                
                                       ,                                        
                                Fort Washington                                 
                                       ,                                        
                                       PA                                       
                                     19034                                      
             (Address of Principal Executive Offices and Zip Code)              
             Registrant's telephone number, including area code: (              
                                      215                                       
                                       )                                        
                                    784-6000                                    
                                                                                
                                      N/A                                       
         (Former Name or Former Address, if Changed Since Last Report)          
              ____________________________________________________              

Check the appropriate box below if the Form 8-K filing is intended to 
simultaneously satisfy the filing obligation of the registrant under any of 
the following provisions (
see
General Instruction A.2. below):

   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)                   
   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)                  
   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  
   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  

Securities registered pursuant to Section 12(b) of the Act:

       Title of each class         Trading Symbol(s)   Name of each exchange on which registered 
 Common Stock, Without Par Value         KLIC                  The Nasdaq Global Market          

Indicate by check mark whether the registrant is an emerging growth company as 
defined in Rule 405 of the Securities Act of 1933 ((s)230.405 of this chapter) 
or Rule 12b-2 of the Securities Exchange Act of 1934 ((s)240.12b-2 of this 
chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has 
elected not to use the extended transition period for complying with any new 
or revised financial accounting standards provided pursuant to Section 13(a) 
of the Exchange Act.

-------------------------------------------------------------------------------
Item 2.02     Results of Operations and Financial Condition.
On May 1, 2024, Kulicke and Soffa Industries, Inc. (the "Company") issued a 
press release with respect to its financial results for its second fiscal 
quarter ended March 30, 2024. A copy of this press release is furnished as 
Exhibit 99.1 to this report, and is incorporated by reference into this Item 
2.02 as if fully set forth herein.
The information in this report, furnished under "Item 2.02 Results of 
Operations and Financial Condition," shall not be deemed "filed" for purposes 
of Section 18 of the Securities Exchange Act of 1934, as amended (the 
"Exchange Act"), nor shall it be deemed incorporated by reference in any 
filing under the Securities Act of 1933, as amended, or the Exchange Act, 
except as shall be expressly set forth by specific reference in such filing.


Item 9.01     Financial Statements and Exhibits.  
(d)           Exhibits.                           
Exhibit No.   Description                         
99.1          Press Release dated May 1, 2024                                       
104           Inline XBRL for the cover page of this Current Report on Form 8K.     

-------------------------------------------------------------------------------
                                   SIGNATURE                                    
                                                                                
Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned hereunto duly authorized.



KULICKE AND SOFFA INDUSTRIES, INC.                                                              
                                                                                                
Date: May 1, 2024   By:      /s/ LESTER WONG                                                    
                    Name:    Lester Wong                                                        
                    Title:   Executive Vice President and Chief Financial Officer            
                             (principal financial officer and principal accounting officer)  
                                                                                             


                                                                    Exhibit 99.1

                                       
              Kulicke & Soffa Pte. Ltd.
              23A Serangoon North Ave 5
                       Singapore 554369
                     +65 6880-9600 main
               Co. Regn. No. 199902120H
     Kulicke and Soffa Industries, Inc.
                    1005 Virginia Drive
          Fort Washington, PA 19034 USA
                   +1-215-784-6000 main
                            www.kns.com


              Kulicke & Soffa Reports Second Quarter 2024 Results               
        Focuses on Operational Efficiency; Increases Repurchase Activity        
Singapore - May 1, 2024
-
Kulicke and Soffa Industries, Inc.
(NASDAQ: KLIC) ("Kulicke & Soffa," "K&S," "our," or the "Company"), today 
announced financial results of its second fiscal quarter ended March 30, 2024. 
The Company reported second quarter net revenue of $172.1 million, net loss of 
$102.7 million, representing EPS of $(1.83) per fully diluted share, and 
non-GAAP net loss of $53.2 million, representing non-GAAP EPS of $(0.95) per 
fully diluted share.
As announced on March 11, 2024, the Company had anticipated pre-tax charges, 
including impairments, relating to the cancellation of Project W (the 
"Project"), to be in the range of $110 million and $130 million (the "Expected 
Range") and to be incurred primarily in the second fiscal quarter 2024. Based 
on the actual second fiscal quarter 2024 financial results, the pre-tax 
charges, including impairments, were below the Expected Range at $105.5 
million.

                                                                           
                       Quarterly Results - U.S. GAAP                       
                                             Change vs.       Change vs.   
                         Fiscal Q2 2024    Fiscal Q2 2023   Fiscal Q1 2024 
                                                                           
     Net Revenue         $172.1 million      down 0.5%         up 0.5%     
                                                                           
     Gross Margin             9.6%         down 3900 bps    down 3710 bps  
 Loss from Operations   $(105.2) million    down 932.6%      down 6311.2%  
   Operating Margin         (61.1)%        down 6840 bps    down 6210 bps  
       Net Loss         $(102.7) million    down 782.7%      down 1204.9%  
      Net Margin            (59.7)%        down 6840 bps    down 6510 bps  
    EPS - Diluted           $(1.83)         down 803.8%      down 1243.8%  



                                                                          
                       Quarterly Results - Non-GAAP                       
                                            Change vs.       Change vs.   
                        Fiscal Q2 2024    Fiscal Q2 2023   Fiscal Q1 2024 
                                                                          
 Loss from Operations   $(50.2) million    down 345.9%      down 560.5%   
   Operating Margin         (29.2)%       down 4100 bps    down 3560 bps  
       Net Loss         $(53.2) million    down 342.8%      down 413.6%   
      Net Margin            (30.9)%       down 4360 bps    down 4080 bps  
    EPS - Diluted           $(0.95)         down 350%       down 416.7%   

A reconciliation between the GAAP and non-GAAP adjusted results is provided in 
the financial tables included at the end of this press release. See also the 
"Use of non-GAAP Financial Results" section of this press release.

                                       1                                        
-------------------------------------------------------------------------------

Fusen Chen, Kulicke & Soffa's President and Chief Executive Officer, stated, 
"Despite a shifting Advanced Display market, we remain nimble and efficiency 
focused. We are preparing for broader Ball Bonder demand recovery and have 
reallocated Advanced Display resources to support growing demand and activity 
within Thermocompression and Advanced Dispense. We look forward to achieve new 
customer and market adoption milestones over the coming quarters."
During its recently completed quarter, the Company's Ball Bonder revenue has 
grown by more than 50% over the same period in the prior fiscal year. K&S is 
preparing to further ramp its Ball Bonder supply chain and production 
activities, in support of General Semiconductor recovery, which includes 
fulfilling a sizeable order from a fast-growing Assembly and Test customer of 
1,000 RAPID" Pro systems, as announced earlier today.

Second Quarter Fiscal 2024 Financial Highlights
.
Net revenue of $172.1 million.
.
Gross margin of 9.6%.

Gross margin includes a one-time charge of $57.3 million of certain inventory 
write down adjustments and purchase order cancellation charges of $2.8 
million, substantially due to, and as previously anticipated by, the 
cancellation of Project W.
.
Net loss of $102.7 million or $(1.83) per share; non-GAAP net loss of $53.2 
million or $(0.95) per fully diluted share.

In addition to the inventory write-down adjustments, net loss also includes a 
one-time impairment charge of $44.5 million on long-lived assets related to 
the cancellation of Project W and employee termination benefits of $2.9 
million.
.
GAAP cash flow from operations of $(20.1) million; Adjusted free cash flow of 
$(26.7) million.
.
Cash, cash equivalents, and short-term investments were $634.7 million as of 
March 30, 2024.
.
The Company repurchased a total of 0.8 million shares of common stock at a 
cost of $37.3 million.

Third Quarter Fiscal 2024 Outlook
K&S currently expects net revenue in the third quarter of fiscal 2024 ending 
June 29, 2024 to be approximately $180 million +/- $10 million, GAAP diluted 
EPS to be approximately $0.17 +/- 10%, and non-GAAP diluted EPS to be 
approximately $0.30 +/- 10%.
A reconciliation between the GAAP and non-GAAP financial outlook is provided 
in the financial tables included at the end of this press release.

Earnings Conference Webcast
A webcast to discuss these results will be held on May 2, 2024, begi
nning at 8:00 am EDT.
The live webcast link, supplemental earnings presentation, and archived 
webcast will be available at
investor.kns.com
. To access the audio-only portion of the live webcast, parties may call 
+1-877-407-8037, or internationally, +1-201-689-8037.
An audio-only replay of the webcast will also be available approximately one 
hour after the completion of the live call by calling +1-877-660-6853, or 
internationally, +1-201-612-7415 and referencing access code 13743539.


                                       2                                        
-------------------------------------------------------------------------------

Use of Non-GAAP Financial Results
In addition to U.S. GAAP ("GAAP") results, this press release also contains 
the following non-GAAP financial results: income from operations, operating 
margin, net income, net margin, net income per fully diluted share and 
adjusted free cash flow. The Company's non-GAAP results exclude amortization 
related to intangible assets acquired through business combinations, costs 
associated with restructuring and severance, equity-based compensation, 
acquisition and integration costs, impairment relating to assets acquired 
through business combinations, long-lived asset impairment relating to 
business cessation or disposal, impairment relating to equity investments, 
income tax expense/benefit arising from discrete tax items triggered by 
acquisition, disposal of business (both via a sale or an abandonment), 
restructuring and significant changes in tax laws, gain/loss on disposal of 
business, as well as tax benefits or expenses associated with the foregoing 
non-GAAP items. The non-GAAP adjustments may or may not be infrequent or 
nonrecurring in nature, but are a result of periodic or non-core operating 
activities. These non-GAAP measures are consistent with the way management 
analyzes and assesses the Company's operating results. The Company believes 
these non-GAAP measures enhance investors' understanding of the Company's 
underlying operational performance, as well as their ability to compare the 
Company's period-to-period financial results and the Company's overall 
performance to that of its competitors.
Management uses both GAAP metrics as well as these non-GAAP metrics to 
evaluate the Company's operating and financial results. Non-GAAP financial 
measures may not provide information that is directly comparable to that 
provided by other companies in the Company's industry, as other companies in 
the industry may calculate non-GAAP financial results differently. In 
addition, there are limitations in using non-GAAP financial measures because 
the non-GAAP financial measures are not prepared in accordance with GAAP, may 
be different from non-GAAP financial measures used by other companies and 
exclude expenses that may have a material impact on the Company's reported 
financial results. The presentation of non-GAAP items is meant to supplement, 
but not substitute for, GAAP financial measures or information. The Company 
believes the presentation of non-GAAP results in combination with GAAP results 
provides better transparency to the investment community when analyzing 
business trends, providing meaningful comparisons with prior period 
performance and enhancing investors' ability to view the Company's results 
from management's perspective. A reconciliation of each non-GAAP financial 
measure to the most directly comparable GAAP measure discussed in this press 
release is contained in the financial tables at the end of this press release.



                                       3                                        
-------------------------------------------------------------------------------

About Kulicke & Soffa
Founded in 1951, Kulicke & Soffa specializes in developing cutting-edge 
semiconductor and electronics assembly solutions enabling a smart and more 
sustainable future. Our ever-growing range of products and services supports 
growth and facilitates technology transitions across large-scale markets, such 
as advanced display, automotive, communications, compute, consumer, data 
storage, energy storage and industrial.
Caution Concerning Results, Forward-Looking Statements and Certain Risks 
Related to our Business
In addition to historical statements, this press release contains statements 
relating to future events and our future results. These statements are 
"forward-looking" statements within the meaning of the Private Securities 
Litigation Reform Act of 1995. While these forward-looking statements 
represent our judgments and future expectations concerning our business, 
including the importance and competitiveness of our advanced display products 
and other emerging technology transitions, a number of risks, uncertainties 
and other important factors could cause actual developments and results to 
differ materially from our expectations. These factors include, but are not 
limited to, the continued review of the impact of the cancellation of the 
Project on our business, our ability to repurpose assets deployed or developed 
for the Project to other parts of our business, our ability to seek potential 
recourse, claims and remedies arising from the cancellation of the Project, 
the persistent macroeconomic headwinds on our business, actual or potential 
inflationary pressures, interest rate and risk premium adjustments, falling 
customer sentiment, or economic recession caused directly or indirectly by 
geopolitical tensions, our ability to develop, manufacture and gain market 
acceptance of new products, our ability to operate our business in accordance 
with our business plan and the other factors listed or discussed in our Annual 
Report on Form 10-K for the fiscal year ended September 30, 2023, filed on 
November 16, 2023, and our other filings with the Securities and Exchange 
Commission. Kulicke and Soffa Industries, Inc. is under no obligation to (and 
expressly disclaims any obligation to) update or alter its forward-looking 
statements whether as a result of new information, future events or otherwise.



Contact:

                                       
Kulicke and Soffa Industries, Inc.     
Joseph Elgindy                         
Finance                                
P: +1-215-784-7518                     
                                       
                                       

                                       4                                        
-------------------------------------------------------------------------------

                       KULICKE AND SOFFA INDUSTRIES, INC.                       
                CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS                 
               (In thousands, except per share and employee data)               
                                  (Unaudited)                                   

                                                                                                                 
                                               Three months ended                      Six months ended          
                                        March 30, 2024      April 1, 2023       March 30, 2024      April 1, 2023
                                                                                                                 
                                                                                                                 
                                                                                                                 
                                                                                                                 
Net revenue                             $   172,074          $ 173,021          $  343,263          $ 349,254    
                                                                                                                 
                                                                                                                 
                                                                                                                 
                                                                                                                 
                                                                                                                 
Cost of sales                               155,603             88,929             246,896            176,456    
                                                                                                                 
                                                                                                                 
                                                                                                                 
                                                                                                                 
                                                                                                                 
Gross profit                                 16,471             84,092              96,367            172,798    
                                                                                                                 
Operating expenses:                                                                                              
Selling, general and administrative          35,185             33,063              75,231             73,563    
Research and development                     37,704             35,999              74,514             70,507    
Impairment charges                           44,472                  -              44,472                  -    
Amortization of intangible assets             1,325              1,563               2,672              2,957    
Acquisition-related costs                         -                334                   -                441    
Restructuring                                 2,940                504               2,940                879    
Total operating expenses                    121,626             71,463             199,829            148,347    
                                                                                                                 
                                                                                                                 
                                                                                                                 
                                                                                                                 
                                                                                                                 
(Loss) / Income from operations           (105,155)             12,629           (103,462)             24,451    
                                                                                                                 
Other income (expense):                                                                                          
Interest income                               8,848              8,000              18,747             14,559    
Interest expense                               (18)               (32)                (40)               (66)    
                                                                                                                 
(Loss) / Income before income taxes        (96,325)             20,597            (84,755)             38,944    
Income tax expense                            6,355              5,556               8,632              9,314    
                                                                                                                 
Net (loss) / income                     $ (102,680)          $  15,041          $ (93,387)          $  29,630    
                                                                                                                 
Net (loss) / income per share:                                                                                   
Basic                                   $    (1.83)          $    0.27          $   (1.66)          $    0.52    
Diluted                                 $    (1.83)          $    0.26          $   (1.66)          $    0.51    
                                                                                                                 
Cash dividends declared per share       $      0.20          $    0.19          $     0.40          $    0.38    
                                                                                                                 
Weighted average shares outstanding:                                                                             
Basic                                        56,154             56,684              56,402             56,868    
Diluted                                      56,154             57,577              56,402             57,739    


                                                                                                                    
                                                  Three months ended                      Six months ended          
Supplemental financial data:               March 30, 2024      April 1, 2023      March 30, 2024      April 1, 2023 
Depreciation and amortization                $ 6,967             $ 6,542            $ 14,952           $ 12,155     
Capital expenditures                           3,846              17,383               7,379             33,034     
Equity-based compensation expense:                                                                                  
Cost of sales                                    363                 323                 722                631     
Selling, general and administrative            4,103               3,731               9,783              8,598     
Research and development                       1,766               1,325               3,584              2,671     
Total equity-based compensation expense      $ 6,232             $ 5,379            $ 14,089           $ 11,900     



                                                         
                                     As of               
                       March 30, 2024      April 1, 2023 
                                                         
Number of employees        2,925              3,089      

                                       5                                        
-------------------------------------------------------------------------------

                       KULICKE AND SOFFA INDUSTRIES, INC.                       
                     CONSOLIDATED CONDENSED BALANCE SHEETS                      
                                 (In thousands)                                 
                                  (Unaudited)                                   

                                                                                                    
                                                                       As of                        
                                                       March 30, 2024      September 30, 2023       
                                            ASSETS                                                  
CURRENT ASSETS                                                                                      
Cash and cash                                          $   359,748           $   529,402            
equivalents                                                                                         
                                                                                                    
Short-term                                                 275,000               230,000            
investments                                                                                         
Accounts and other receivable, net of allowance for        194,819               158,601            
doubtful accounts of $49 and $49, respectively                                                      
Inventories, net                                           180,541               217,304            
Prepaid expenses and                                        40,309                53,751            
other current assets                                                                                
                                                                                                    
TOTAL CURRENT                                            1,050,417             1,189,058            
ASSETS                                                                                              
                                                                                                    
Property, plant and                                         65,003               110,051            
equipment, net                                                                                      
Operating                                                   36,653                47,148            
right-of-use assets                                                                                 
Goodwill                                                    89,082                88,673            
Intangible                                                  27,139                29,357            
assets, net                                                                                         
Deferred                                                    18,101                31,551            
tax assets                                                                                          
Equity                                                       2,254                   716            
investments                                                                                         
Other assets                                                10,058                 3,223            
TOTAL ASSETS                                           $ 1,298,707           $ 1,499,777            
                                                                                                    
                             LIABILITIES AND SHAREHOLDERS' EQUITY                                   
CURRENT LIABILITIES                                                                                 
                                                                                                    
Accounts payable                                            51,487                49,302            
Operating lease                                              7,021                 6,574            
liabilities                                                                                         
Accrued expenses and other                                  90,126               103,005            
current liabilities                                                                                 
Income taxes                                                17,102                22,670            
payable                                                                                             
TOTAL CURRENT                                              165,736               181,551            
LIABILITIES                                                                                         
                                                                                                    
                                                                                                    
Deferred tax                                                36,377                37,264            
liabilities                                                                                         
Income taxes                                                36,647                52,793            
payable                                                                                             
Operating lease                                             34,307                41,839            
liabilities                                                                                         
Other                                                       13,463                11,769            
liabilities                                                                                         
TOTAL                                                      286,530               325,216            
LIABILITIES                                                                                         
                                                                                                    
SHAREHOLDERS' EQUITY                                                                                
Common stock,                                              584,626               577,727            
no par value                                                                                        
Treasury                                                 (794,193)             (737,214)            
stock, at cost                                                                                      
Retained                                                 1,239,956             1,355,810            
earnings                                                                                            
Accumulated other                                         (18,212)              (21,762)            
comprehensive loss                                                                                  
TOTAL SHAREHOLDERS'                                    $ 1,012,177           $ 1,174,561            
EQUITY                                                                                              
                                                                                                    
TOTAL LIABILITIES AND                                  $ 1,298,707           $ 1,499,777            
SHAREHOLDERS' EQUITY                                                                                

                                       6                                        
-------------------------------------------------------------------------------

                       KULICKE AND SOFFA INDUSTRIES, INC.                       
                CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS                 
                                 (In thousands)                                 
                                  (Unaudited)                                   

                                                                                                            
                                          Three months ended                      Six months ended          
                                   March 30, 2024      April 1, 2023      March 30, 2024      April 1, 2023 
Net cash (used in)/provided         $ (20,148)          $   1,820          $ (27,479)          $  86,936    
by operating activities                                                                                     
Net cash provided by/ (used              3,429          (147,283)            (57,112)          (186,197)    
in) investing activities                                                                                    
Net cash used in                      (47,672)           (16,681)            (85,796)           (72,911)    
financing activities                                                                                        
Effect of exchange rate changes          (521)                633                 733              5,737    
on cash and cash equivalents                                                                                
Changes in cash and                   (64,912)          (161,511)           (169,654)          (166,435)    
cash equivalents                                                                                            
Cash and cash equivalents,             424,660            550,613             529,402            555,537    
beginning of period                                                                                         
Cash and cash equivalents,          $  359,748          $ 389,102          $  359,748          $ 389,102    
end of period                                                                                               
                                                                                                            
Short-term                             275,000            345,000             275,000            345,000    
investments                                                                                                 
Total cash, cash equivalents        $  634,748          $ 734,102          $  634,748          $ 734,102    
and short-term investments                                                                                  
                                                                                                            



                                       7                                        
-------------------------------------------------------------------------------

                          Reconciliation of U.S. GAAP                           
            to Non-GAAP Income from Operations and Operating Margin             
                       (In thousands, except percentages)                       
                                  (Unaudited)                                   

                                                                                                         
                                                                   Three months ended                    
                                                March 30, 2024      April 1, 2023      December 30, 2023 
Net revenue                                      $  172,074          $ 173,021            $ 171,189      
U.S. GAAP income from operations                  (105,155)             12,629                1,693      
U.S. GAAP operating margin                           (61.1)   %            7.3   %              1.0     %
                                                                                                         
Pre-tax non-GAAP items:                                                                                  
Amortization related to intangible assets             1,325              1,563                1,347      
Restructuring and severance                           2,940                504                    -      
Equity-based compensation                             6,232              5,379                7,857      
Impairment charges                                   44,472                  -                    -      
Acquisition-related costs                                 -                334                    -      
Non-GAAP income from operations                  $ (50,186)          $  20,409            $  10,897      
Non-GAAP operating margin                            (29.2)   %           11.8   %              6.4     %
                                                                                                         


                                       8                                        
-------------------------------------------------------------------------------

 Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and Non-GAAP Net 
                                   Margin and                                   
        U.S. GAAP net income per share to Non-GAAP net income per share         
             (In thousands, except percentages and per share data)              
                                  (Unaudited)                                   

                                                                                                         
                                                                   Three months ended                    
                                                March 30, 2024      April 1, 2023      December 30, 2023 
Net revenue                                      $  172,074          $ 173,021            $ 171,189      
U.S. GAAP net (loss) / income                     (102,680)             15,041                9,293      
U.S. GAAP net margin                                 (59.7)   %            8.7   %              5.4     %
                                                                                                         
Non-GAAP adjustments:                                                                                    
Amortization related to intangible assets             1,325              1,563                1,347      
Restructuring and severance                           2,940                504                    -      
Equity-based compensation                             6,232              5,379                7,857      
Impairment charges                                   44,472                  -                    -      
Acquisition-related costs                                 -                334                    -      
Net income tax benefit on non-GAAP items            (5,534)              (892)              (1,516)      
Total non-GAAP adjustments                       $   49,435          $   6,888            $   7,688      
Non-GAAP net (loss) / income                     $ (53,245)          $  21,929            $  16,981      
Non-GAAP net margin                                  (30.9)   %           12.7   %              9.9     %
                                                                                                         
U.S. GAAP net (loss) / income per share:                                                                 
Basic                                                (1.83)               0.27                 0.16      
Diluted                                              (1.83)               0.26                 0.16      
(a)                                                                                                      
                                                                                                         
Non-GAAP adjustments per share:                                                                          
(b)                                                                                                      
Basic                                                  0.88               0.12                 0.14      
Diluted                                                0.88               0.12                 0.14      
                                                                                                         
Non-GAAP net (loss) / income per share:                                                                  
Basic                                            $   (0.95)          $    0.39            $    0.30      
Diluted                                          $   (0.95)          $    0.38            $    0.30      
(c)                                                                                                      
                                                                                                         
Weighted average shares outstanding:                                                                     
Basic                                                56,154             56,684               56,650      
Diluted                                              56,154             57,577               57,023      
                                                                                                         

(a)
GAAP diluted net earnings per share reflects any dilutive effect of 
outstanding restricted stock, but that effect is excluded when calculating 
GAAP diluted net loss per share because it would be anti-dilutive.
(b)
Non-GAAP adjustments per share include amortization related to intangible 
assets acquired through business combinations, costs associated with 
restructuring and severance, acquisition and integration costs, equity-based 
compensation expenses, long-lived asset impairment relating to business 
cessation or disposal, and income tax effects associated with the foregoing 
non-GAAP items.
(c)
Non-GAAP diluted net earnings per share reflects any dilutive effect of 
outstanding restricted stock.

                                       9                                        
-------------------------------------------------------------------------------

       Reconciliation of U.S. GAAP Cash provided by Operating Activities        
                      to Non-GAAP Adjusted Free Cash Flow                       
                       (In thousands, except percentages)                       
                                  (unaudited)                                   


                                                                                                                   
                                                                                  Three months ended               
                                                                    March 30,      April 1,      December 30, 2023 
                                                                      2024           2023                          
U.S. GAAP net cash (used in)/provided by operating activities      $ (20,148)       $ 1,820         $ (7,331)      
Expenditures for property, plant and equipment                        (6,571)      (10,637)           (4,426)      
Proceeds from sales of property, plant and equipment                        -           235                 -      
                                                                                                                   
Non-GAAP adjusted free cash flow                                     (26,719)       (8,582)          (11,757)      
                                                                                                                   
                                                                                                                   
                                                                                                                   
                                                                                                                   
                                                                                                                   
                                                                                                                   
                                                                                                                   
                                                                                                                   
                                                                                                                   


                                       10                                       
-------------------------------------------------------------------------------

                Reconciliation of U.S. GAAP to Non-GAAP Outlook                 
                      (In millions, except per share data)                      
                                  (Unaudited)                                   


                                                                                               
                                                       Third quarter of fiscal                 
                                                      2024 ending June 29, 2024                
                                        GAAP Outlook        Adjustments       Non-GAAP Outlook 
Net revenue                             $180 million             -              $180 million   
                                       +/- $10 million                        +/- $10 million  
                                                                                               
Operating expenses                      $79.6 million       $7.6 million       $72.0 million   
                                           +/- 2%               B,C                +/- 2%      
Diluted EPS                                 $0.17              $0.13               $0.30       
(1)                                        +/- 10%           A, B, C,D            +/- 10%      
                                                                                               
Non-GAAP                                                                                       
Adjustments                                                                                    
A. Equity-based compensation                                                        0.4        
- Cost of sales                                                                                
B. Equity-based compensation - Selling, general                                     6.3        
and administrative and Research and development                                                
C. Amortization related                                                             1.3        
to intangible assets                                                                           
D. Net income tax effect                                                           (0.6)       
of the above items                                                                             
                                                                                               

(1) GAAP and non-GAAP diluted EPS based on approximately 55.4 million diluted 
weighted average shares outstanding.

The tables above reconcile our GAAP to non-GAAP guidance based on the current 
outlook. The guidance does not incorporate the impact of any potential 
business combinations, divestitures, restructuring activities, strategic 
investments and other significant transactions. The timing and impact of such 
items are dependent on future events that may be uncertain or outside of our 
control.

                                       11                                       
{graphic omitted}
{graphic omitted}
{graphic omitted}